The Penn Difference
Penn Radiation Oncology is a national leader in clinical care, research and education. Penn Medicine provides patients with more options for treating their cancer and is one of the only health systems in the world that offers a full range of radiation therapies, including CyberKnife®, Gamma Knife® and proton therapy.
CyberKnife is a highly sophisticated form of radiation therapy with several potential benefits for individuals with solid tumors. However, all patients are different and all cancers are different, so it may not be the right course of treatment for everyone.
In addition to every form of advanced radiation therapy, Penn Medicine researchers and clinicians participate in clinical trials available at only a select group of sites in the world. Having access to every treatment option allows Penn physicians to aptly determine the correct treatment plan to meet the individual needs of each patient.
CyberKnife at Pennsylvania Hospital is fully integrated within Penn Radiation Oncology. It is backed by the resources of Penn's Abramson Cancer Center, one of a select group of cancer centers in the country awarded the prestigious designation of Comprehensive Cancer Center by the National Cancer Institute (NCI), and the expertise and support services offered at the Joan Karnell Cancer Center at Pennsylvania Hospital.
Penn Radiation Oncology:
- Is one of the largest and most respected clinical services in the region.
- Offers a wide range of radiation therapy services, including many that combine radiation therapy with chemotherapy and/or surgery.
- Uses the latest technology available to treat many types of cancer, from the most common to the most complex.
- Is a leader in radiation therapy research to discover the cancer treatments of tomorrow.